Flu

Main article: Viruses

Molecular model of influenza virus, 2019

According to 2020 estimates from the Center for Disease Control and Prevention and the USA World Organization, health care up to 650,000 people die each year from respiratory illnesses caused by seasonal flu.

Vaccines

2025: Russia will conduct clinical studies of the first domestic combined vaccine against influenza and COVID-19

Holding "" Natsimbio received Ministry of Health Russia permission to conduct the first phase of clinical trials vaccines for the prevention of influenza coronavirus and infection. The combined drug "" UltrixCovey was developed jointly with (M.P. Chumakov Federal Scientific Center Polio Institute) - a subordinate institution. Ministry of Education and Science This was announced on May 20, 2025 by representatives. Rostec More. here

2022: Rostec and ISKCH agree on further trials of a single vaccine against coronavirus and influenza

The Human Stem Cell Institute (ISKJ) and Rostec pharmaceutical holding Natsimbio have signed an agreement on clinical research, production and commercialization of a jointly developed combined vaccine for the prevention of influenza and coronavirus infection. The company "Natsimbio" announced this on December 29, 2022. Read more here.

Drugs for the treatment and prevention of influenza

2025: Petrovax Farm launched a new form of production of Polyoxidonium in drops

Petrovax Pharm is bringing to market an additional form of Polyoxidonium (azoxymer bromide) 6 mg drops for topical use. The solution will appear in pharmacies in July-August 2025. This form is developed for convenient treatment and prevention of ARVI, influenza and ENT diseases in adults and children, starting from 6 months. The company announced this on July 10, 2025. Read more here.

Subtypes

Swine flu (H1N1)

Main article: Swine flu

Researches

Influenza Research Institute

Main article: Influenza Research Institute

Technology to fight the flu

2021: The world's first consumer device to detect coronavirus and flu in the air comes out

In mid-August 2021, - CanadianAIstartup Stratuscent which developed the technology of digital smell, presented the world's first AI air quality monitor, Noze which will be able to detect the presence of coronavirus particles COVID-19 flu in the air. More. here

History

2025: Discovery: 'Sleeping' cancer cells in lungs are activated by coronavirus and flu

Scientists have found that dormant malignant cells in the lungs of patients who have undergone cancer can wake up under the influence of common respiratory infections, including COVID-19 and influenza. The study revealed a mechanism for activating metastatic cells that are able to be at rest for decades after successful treatment of breast cancer and other oncology. The results of the work also showed an almost twofold increase in cancer deaths among patients infected with the SARS-CoV-2 coronavirus. This became known at the end of July 2025. Read more here.

2024: Reduction in the incidence of influenza in Russia by 27.1% to 121.67 per 100 thousand population

The incidence of influenza in the Russian Federation in 2024 decreased by 27.1% compared to 2023 to 121.67 per 100 thousand population, but it was still 3 times higher than the average long-term values ​ ​ (38.93 per 100 thousand population). The data follows from the report of Rospotrebnadzor, published in June 2025. The incidence of influenza in the child population decreased by 33.7%, but was 2.9 times higher than the long-term average. The highest incidence - in the age group of 1-2 years - 494.7 per 100 thousand children and in children under 1 year old - 416.6 per 100 thousand.^[1]

2022: Flu incidence rises 11-fold

From January to October 2022, the incidence of influenza among Russians was 7.87 per 100,000 population, which is 11 times more compared to the same period in 2021, when the incidence was at 0.71 per 100,000 population. Such data in mid-December 2022 led to. Rospotrebnadzor

On December 13, 2022, Rospotrebnadzor presented data on the epidemiological situation in the regions. Over the week from December 5 to 11, 2022, the incidence of SARS and influenza in Russia increased by 35.4% compared to the previous one, the national average was exceeded in 37 regions. The highest incidence rates are observed in the Astrakhan, Vologda, Kostroma and Tyumen regions, the republics of Buryatia, Komi and Yakutia (Sakha), as well as in the Khanty-Mansi, Chukotka and Yamalo-Nenets Autonomous Districts. Rospotrebnadzor noted that swine flu A (H1N1) prevails among the strains, it was already detected in 82 regions.

The incidence of influenza in 2022 increased 11 times

An 11-fold increase in the incidence of influenza in Russia is associated with a decrease in the activity of the coronavirus COVID-19, an infectious disease doctor, head of the Department of Infectious Diseases of the Russian National Research Medical University named after N.I. Pirogov, Professor Vladimir Nikiforov told Ленте.ру. In nature, everything is balanced, and a certain antagonism is observed inside the microcosm, the doctor shared. So, for several years he won COVID-19, but he could not rule for a long time.

They have one point of attraction, they did not divide the "feeder," that is, our mortal body with you. The severe delta strain was gradually replaced by a lighter omicron, many people were ill with it, and the incidence went down, and the holy place is not empty. For a long time there was no flu, we got a little out of it, collective immunity to it decreased, unfortunately, not everyone was vaccinated, and the flu came, "Nikiforov explained.

A certain role, according to the infectious disease specialist, was played by wearing masks. The flu is still less contagious than covid. For him, the mask is more "harmful," it protects more from him than from covid, and therefore there was also less of it, "he explained.[2]

1927

"Spark," 1927. The inscription on the cover: "Do not kiss! Through kisses at the meeting, the most common disease of this year is the flu! "

First photo of the virus

First ever photo of a flu virus

Notes